Gilead Sciences
Senior Director & Head of Innovation & New Product Planning, Delivery Devices, Packaging, and Sterile Process Development
Membership Participation
Membership Participation
Participating in the Consortium
The activities and efforts of the Subcutaneous Drug Development and Delivery Consortium provide an opportunity for participating organizations to proactively impact and drive value across SC drug development and delivery and ultimately provide value to the larger community.
SC Consortium Officers:
Donna French, PhD
President
Sachin Mittal, PhD
Vice President
Monica Adams, PhD
Marketing Officer
David Kang, PhD
Treasurer
SC Consortium: Tier 1 Members
SC Consortium: Tier 2 Members
SC Consortium: Governing Board/Tier 1 Members
BMS
Scientific Director, Drug Delivery and Product Integration
MERCK
Senior Director, Biologics Development and Biopharmaceutics
Immunogenicity Co-Lead
BD
Business Director
Advanced Drug Delivery Solutions Wearables Portfolio
BMS
Senior Director, Sterile Product Development
High-Dose/High-Volume Co-Lead
ASTRA ZENECA
Senior Director, Drug Product Development
High-Dose/High-Volume Co-Lead
MERCK
Executive Director, Sterile & Specialty Product Development
SC Consortium Vice President
Bioavailability Co-Lead
PFIZER
Associate Research Fellow
Pharmaceutical R&D
The SC Consortium has been proudly engaging with Charles Rivers Associates since its inception in 2018
Robert Broadnax
NJ
Vice President
PROJECT LEAD
Brian Carpenter
NJ
Principal
PROJECT LEAD
Matthew Potter
NY
Senior Associate
ENGAGEMENT LEAD
Ella Brown
MA
Associate
PROJECT SUPPORT
© 2025 Subcutaneous Drug Development & Delivery Consortium
English